Please login to the form below

Not currently logged in
Email:
Password:

JPA adds to Washington team

Jeff Goldfarb to join PR agency as VP
JPA Jeff Goldfarb

JPA Health Communications has expanded its Washingtom team with the appointment of Jeff Goldfarb as VP.

Goldfarb has two decades' experience in marketing, branding and communications, said JPA, with significant experience in the healthcare industry. He joins from Matthews Media Group (MMG).

As VP and senior strategist at MMG, Goldfarb developed communications plans and ran patient recruitment initiatives of clinical trials. He also managed public health communications programmes for the Food and Drug Administration and National Cancer Institute.

Before joining MMG, Goldfarb worked on marketing programmes for products such as Claritin and Glucophage. He previously worked for the agency Trahan, Burden, Charles where he managed marketing objectives for the likes of Blue Cross Blue Shield of Maryland and the Baltimore Ravens.

In his new role Goldfarb will 'lead several client projects, participate in new business efforts and support staff development', JPA told PMLiVE. He will support pharmaceutical clients and non-profit organisations, and will start out with a team of four.

“We are thrilled to welcome Jeff to the agency,” said Carrie Jones, principal and managing director of JPA. “His extensive communications experience in the healthcare industry will help us deliver the high-quality results our clients expect.”

30th January 2014

From: Marketing

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...